A novel modification of a flow cytometric assay of phosphorylated STAT1 in whole blood monocytes for immunomonitoring of patients on IFNα regimen

Scandinavian Journal of Immunology

Volumn 67, Issue 1, 2008, Pages 95-102

  Vakkila, J ^a   Nieminen, U ^b   Siitonen, S ^b   Turunen, U ^b   Halme, L ^b   Nuutinen, H ^b   Mustonen, H ^b   Puolakkainen, P ^b   Farkkila M ^b   Repo, H ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; STAT1 PROTEIN;

ADULT; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; MALE; MONOCYTE; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADULT; ANIMALS; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HUMANS; INTERFERON-ALPHA; MALE; MICE; MIDDLE AGED; MONITORING, IMMUNOLOGIC; MONOCYTES; PHOSPHORYLATION; STAT1 TRANSCRIPTION FACTOR;

EID: 36749050386     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.02028.x     Document Type: Article

References (24)

1. Vakkila J, Thomson AW, Vettenranta K, Sariola H, Saarinen-Pihkala UM. Dendritic cell subsets in childhood and in children with cancer: relation to age and disease prognosis. Clin Exp Immunol 2004 135:455 61.
2. O'Shea JJ, Gadina M, Schreiber RD. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 2002 109 (Suppl. S121 31.
3. Marodi L, Goda K, Palicz A, Szabo G. Cytokine receptor signalling in neonatal macrophages: defective STAT-1 phosphorylation in response to stimulation with IFN-gamma. Clin Exp Immunol 2001 126:456 60.
4. Perez OD, Nolan GP. Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat Biotechnol 2002 20:155 62.
5. Irish JM, Hovland R, Krutzik PO et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004 118:217 28.
6. Lesinski GB, Kondadasula SV, Crespin T et al. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy. J Natl Cancer Inst 2004 96:1331 42.
7. Tochizawa S, Ohmoto Y, Mori T. A novel modification of a flow cytometric assay of phosphorylated STAT1 in whole blood lymphocytes for rapid detection of interferon-alpha signal in vivo. J Immunol Methods 2006 313:29 37.
8. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis. The METAVIR Cooperative Study Group. Hepatology 1996 24:289 93.
9. Krutzik PO, Nolan GP. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A 2003 55:61 70.
10. Grace M, Youngster S, Gitlin G et al. Structural and biologic characterization of pegylated recombinant IFN-alpha2b. J Interferon Cytokine Res 2001 21:1103 15.
11. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005 5:331 42.
12. Cella M, Jarrossay D, Facchetti F et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999 5:919 23.
13. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001 294:1540 3.
14. Puoti M, Babudieri S, Rezza G et al. Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? Antivir Ther 2004 9:627 30.
15. Aceti A, Zechini B, Griggi T et al. Undetectable phospho-STAT1 in peripheral blood mononuclear cells from patients with chronic hepatitis C who do not respond to interferon-alpha therapy. Liver Int 2005 25:987 93.
16. Landolfo S, Guarini A, Riera L et al. Chronic myeloid leukemia cells resistant to interferon-alpha lack STAT1 expression. Hematol J 2000 1:7 14.
17. Gilmour KC, Pine R, Reich NC. Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes. Proc Natl Acad Sci U S A 1995 92:10772 6.
18. Fedorak RN, Gangl A, Elson CO et al. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology 2000 119:1473 82.
19. Weber-Nordt RM, Riley JK, Greenlund AC, Moore KW, Darnell JE, Schreiber RD. Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. J Biol Chem 1996 271:27954 61.
20. Cheng F, Wang HW, Cuenca A et al. A critical role for Stat3 signaling in immune tolerance. Immunity 2003 19:425 36.
21. Repo H, Jansson S-E, Leirisalo-Repo M. Flow cytometric determination of CD11b upregualtion in vivo. J Immunol Methods 1993 164:193 202.
22. Vuorte J, Jansson S-E, Repo H. Evaluation of red blood cell lysing solutions in the study of neutrophil oxidative burst by the DCFG assay. Cytometry 2001 43:290 6.
23. Krutzik PO, Nolan GP. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry 2003 55A:61 70.
24. Montag DT, Lotze MT. Successful simultaneous measurement of cell membrane and cytokine induced phosphorylation pathways [CIPP] in human peripheral blood mononuclear cells. J Immunol Methods 2006 313:48 60.